Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Ndi-034858
2. C293mns6tq
3. Schembl20678921
4. Gtpl12155
5. Bdbm424361
6. Ndi034858
7. Us10508120, Compound I-816
8. Us10508120, Compound I-908
9. Hy-150096
10. Cs-0609920
11. Compound I-908 [us20190256519a1]
12. 2272904-53-5
13. N-[(1r,2r)-2-methoxycyclobutyl]-7-(methylamino)-5-[(2-oxo-1-pyridin-2-ylpyridin-3-yl)amino]pyrazolo[1,5-a]pyrimidine-3-carboxamide
14. Pyrazolo(1,5-a)pyrimidine-3-carboxamide, N-((1r,2r)-2-methoxycyclobutyl)-7-(methylamino)-5-((2-oxo(1(2h),2'-bipyridin)-3-yl)amino)-
Molecular Weight | 460.5 g/mol |
---|---|
Molecular Formula | C23H24N8O3 |
XLogP3 | 1.8 |
Hydrogen Bond Donor Count | 3 |
Hydrogen Bond Acceptor Count | 8 |
Rotatable Bond Count | 7 |
Exact Mass | 460.19713666 g/mol |
Monoisotopic Mass | 460.19713666 g/mol |
Topological Polar Surface Area | 126 Ų |
Heavy Atom Count | 34 |
Formal Charge | 0 |
Complexity | 835 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 2 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
ABOUT THIS PAGE
A NDI-034858 manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of NDI-034858, including repackagers and relabelers. The FDA regulates NDI-034858 manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. NDI-034858 API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A NDI-034858 supplier is an individual or a company that provides NDI-034858 active pharmaceutical ingredient (API) or NDI-034858 finished formulations upon request. The NDI-034858 suppliers may include NDI-034858 API manufacturers, exporters, distributors and traders.
NDI-034858 Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of NDI-034858 GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right NDI-034858 GMP manufacturer or NDI-034858 GMP API supplier for your needs.
A NDI-034858 CoA (Certificate of Analysis) is a formal document that attests to NDI-034858's compliance with NDI-034858 specifications and serves as a tool for batch-level quality control.
NDI-034858 CoA mostly includes findings from lab analyses of a specific batch. For each NDI-034858 CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
NDI-034858 may be tested according to a variety of international standards, such as European Pharmacopoeia (NDI-034858 EP), NDI-034858 JP (Japanese Pharmacopeia) and the US Pharmacopoeia (NDI-034858 USP).
LOOKING FOR A SUPPLIER?